Latest news about Henry Schein
Here are some of the most recent media mentions. Use them in your sales prospecting to qualify a prospect's buyer intent and personalize outreach with the latest company updates
Henry Schein has launched the 2025-2027 BOLD+1 Strategic Plan, expecting 2025 as the foundation for long-term earnings growth. The company has restructured into three segments and aims for $75-$100 million in annual cost savings by 2025, with strong Q4 2024 financial performance and a 2.7% sales increase from 2023[5].
Henry Schein announced a strategic investment by KKR, with a $250 million investment making KKR the largest non-index fund shareholder with a 12% stake. Max Lin and William K. 'Dan' Daniel will join Henry Schein's Board of Directors. The company also provided preliminary 2025 financial guidance, expecting low to mid-single digit growth in revenues and non-GAAP diluted EPS[5].
Henry Schein is showcasing innovative dental solutions at the 2025 Chicago Dental Society Midwinter Meeting, highlighting products like the Maxima™ Advanced Chamber Sterilizer, digital technology solutions, and practice management platforms such as Dentrix® and Dentrix Ascend®[3].
Open job positions at Henry Schein
This company is actively hiring to fill these roles. Use this for sales prospecting if your solution assists, augments, or provides an alternative for the growing team and position.
Strategic Account Manager, Medical - North East
Sr. Manager, Federal Sales
Surgical Field Sales Consultant - New England

